Items where Author is "Peters, G. J."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.


Firuzi, O. and Che, P. P. and El Hassouni, B. and Buijs, M. and Coppola, S. and Löhr, M. and Funel, N. and Heuchel, R. and Carnevale, I. and Schmidt, T. and Mantini, G. and Avan, A. and Saso, L. and Peters, G. J. and Giovannetti, E. (2019) Role of c-MET inhibitors in overcoming drug resistance in spheroid models of primary human pancreatic cancer and stellate cells. Cancers, 11 (5).

Leon, L. G. and Funel, N. and Peters, G. J. and Avan, A. and Vistoli, F. and Boggi, U. and Giovannetti, E. (2016) The MEK1/2 inhibitor pimasertib enhances gemcitabine efficacy-letter. Clinical Cancer Research, 22 (10). p. 2594.

Honeywell, R. J. and Avan, A. and Giovannetti, E. and Peters, G. J. (2016) Tissue distribution of crizotinib and gemcitabine combination in a patient-derived orthotopic mouse model of pancreatic cancer. ADMET and DMPK, 4 (4). pp. 327-334.

Avan, A. and Postma, T. J. and Ceresa, C. and Avan, A. and Cavaletti, G. and Giovannetti, E. and Peters, G. J. (2015) Platinum-induced neurotoxicity and preventive strategies: Past, present, and future. Oncologist, 20 (4). pp. 411-432.

This list was generated on Sun Sep 20 23:46:54 2020 EDT.